Emyria Ltd ( (AU:EMD) ) has shared an update.
Emyria Ltd announced the quotation of 2,083,333 fully paid ordinary securities on the ASX, as part of a previously announced transaction. This move is expected to enhance the company’s liquidity and market presence, potentially impacting its financial operations and stakeholder interests positively.
More about Emyria Ltd
Emyria Ltd operates in the healthcare industry, focusing on developing and commercializing innovative medical treatments and technologies. The company is known for its work in clinical trials and drug development, aiming to address unmet medical needs.
YTD Price Performance: 6.67%
Average Trading Volume: 268,859
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$14.74M
Learn more about EMD stock on TipRanks’ Stock Analysis page.